rethinkPeptides Search
Menu
Research citation

Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.

Diabetes, obesity & metabolism

Citation

Abdel-Rahman, Sama M; Al-Shiab, Rama; Shah, Ermeena; Güldan, Mustafa; Ak, Ahmet Bahadır; Yilmaz, Zeynep Y; Fidan, Derya Göksu; Ozbek, Lasin; Kanbay, Mehmet. (2026). Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70506